Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 16/20 | 0.76 |
| ▸ | CCNA2 | P20248 | 10/20 | 0.76 |
| ▸ | CCNA1 | P78396 | 10/20 | 0.76 |
| ▸ | CACNA1B | Q00975 | 4/20 | 0.63 |
| ▸ | CDK1 | P06493 | 9/20 | 0.60 |
| ▸ | CDK5 | Q00535 | 9/20 | 0.60 |
| ▸ | CCNE1 | P24864 | 8/20 | 0.60 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.60 |
| ▸ | CDK5R1 | Q15078 | 6/20 | 0.60 |
| ▸ | CDK7 | P50613 | 5/20 | 0.60 |
| ▸ | DYRK1A | Q13627 | 5/20 | 0.60 |
| ▸ | CDK9 | P50750 | 4/20 | 0.60 |
| ▸ | CCNK | O75909 | 4/20 | 0.60 |
| ▸ | CDK12 | Q9NYV4 | 4/20 | 0.60 |
| ▸ | CCNB2 | O95067 | 4/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.60 |
| ▸ | CCNB3 | Q8WWL7 | 4/20 | 0.60 |
| ▸ | CCNE2 | O96020 | 3/20 | 0.60 |
| ▸ | CDK4 | P11802 | 3/20 | 0.60 |
| ▸ | CCND1 | P24385 | 3/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17628630 | 1.00 | CDK2 (0.76) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17628627 | 0.89 | CDK2 (0.78) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17628625 | 0.89 | CDK2 (0.78) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17639872 | 0.88 | CDK2 (0.73) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL13170162 | 0.87 | CDK2 (1.00) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17450135 | 0.87 | CDK2 (1.00) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17628638 | 0.85 | CDK2 (0.81) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17628641 | 0.85 | CDK2 (0.81) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17628591 | 0.84 | CDK2 (0.74) | CDK2CCNA2CCNA1CACNA1BCDK1 | |
| SCHEMBL17628589 | 0.84 | CDK2 (0.74) | CDK2CCNA2CCNA1CACNA1BCDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10752629-B2 | Calcium channel agonists | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2020-08-25 | — | — | US | disclosed |
| US-20190084984-A1 | CALCIUM CHANNEL AGONISTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-03-21 | — | — | US | disclosed |
| US-10174031-B2 | Calcium channel agonists | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2019-01-08 | — | — | US | disclosed |
| US-20180009810-A1 | CALCIUM CHANNEL AGONISTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2018-01-11 | — | — | US | disclosed |
| US-9796714-B2 | Calcium channel agonists | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160090387-A1 | CALCIUM CHANNEL AGONISTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2016-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009810-A1 | CALCIUM CHANNEL AGONISTS | CACNA1E, CACNA1C, CACNA1S | CDK2 3024/4885CCNA2 3582/4885CCNA1 3624/4885 |
| US-20190084984-A1 | CALCIUM CHANNEL AGONISTS | CACNA1E, CACNA1C, CACNA1S | CDK2 3024/4885CCNA2 3582/4885CCNA1 3624/4885 |
| US-20160090387-A1 | CALCIUM CHANNEL AGONISTS | CACNA1E, CACNA1C, CACNA1S | CDK2 3024/4885CCNA2 3582/4885CCNA1 3624/4885 |
| US-10174031-B2 | Calcium channel agonists | CACNA1E, CACNA1C, CACNA1S | CDK2 3024/4885CCNA2 3582/4885CCNA1 3624/4885 |
| US-10752629-B2 | Calcium channel agonists | CACNA1E, CACNA1C, CACNA1S | CDK2 3024/4885CCNA2 3582/4885CCNA1 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.